» Articles » PMID: 22014578

Macrophage Binding to Receptor VCAM-1 Transmits Survival Signals in Breast Cancer Cells That Invade the Lungs

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2011 Oct 22
PMID 22014578
Citations 317
Authors
Affiliations
Soon will be listed here.
Abstract

Aberrant expression of vascular cell adhesion molecule-1 (VCAM-1) in breast cancer cells is associated with lung relapse, but the role of VCAM-1 as a mediator of metastasis has remained unknown. We report that VCAM-1 provides a survival advantage to breast cancer cells that infiltrate leukocyte-rich microenvironments such as the lungs. VCAM-1 tethers metastasis-associated macrophages to cancer cells via counter-receptor α4-integrins. Clustering of cell surface VCAM-1, acting through Ezrin, triggers Akt activation and protects cancer cells from proapoptotic cytokines such as TRAIL. This prosurvival function of VCAM-1 can be blocked by antibodies against α4-integrins. Thus, newly disseminated cancer cells expressing VCAM-1 can thrive in leukocyte-rich microenvironments through juxtacrine activation of a VCAM-1-Ezrin-PI3K/Akt survival pathway.

Citing Articles

Uncovering immune cell heterogeneity in hepatocellular carcinoma by combining single-cell RNA sequencing with T-cell receptor sequencing.

Gu X, Gu S, Chen Z, Tong J, Li X, Dong H World J Hepatol. 2025; 17(2):99046.

PMID: 40027555 PMC: 11866147. DOI: 10.4254/wjh.v17.i2.99046.


Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy.

Toghraie F, Bayat M, Hosseini M, Ramezani A Cell Oncol (Dordr). 2025; .

PMID: 39998754 DOI: 10.1007/s13402-025-01051-y.


Invasion and metastasis in cancer: molecular insights and therapeutic targets.

Li Y, Liu F, Cai Q, Deng L, OuYang Q, Zhang X Signal Transduct Target Ther. 2025; 10(1):57.

PMID: 39979279 PMC: 11842613. DOI: 10.1038/s41392-025-02148-4.


The Roles of Myeloid Cells in Breast Cancer Progression.

Rivas C, Liu F, Zhang X Adv Exp Med Biol. 2025; 1464():397-412.

PMID: 39821035 DOI: 10.1007/978-3-031-70875-6_19.


Metabolic Reprogramming and Adaption in Breast Cancer Progression and Metastasis.

Zuo Q, Kang Y Adv Exp Med Biol. 2025; 1464():347-370.

PMID: 39821033 DOI: 10.1007/978-3-031-70875-6_17.


References
1.
Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H . Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004; 6(1):17-32. DOI: 10.1016/j.ccr.2004.06.010. View

2.
Fidler I . The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003; 3(6):453-8. DOI: 10.1038/nrc1098. View

3.
Collins B, Deak M, Arthur J, Armit L, Alessi D . In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation. EMBO J. 2003; 22(16):4202-11. PMC: 175797. DOI: 10.1093/emboj/cdg407. View

4.
Lipscomb M, Bice D, Lyons C, Schuyler M, Wilkes D . The regulation of pulmonary immunity. Adv Immunol. 1995; 59:369-455. PMC: 7131473. DOI: 10.1016/s0065-2776(08)60634-3. View

5.
Gocheva V, Wang H, Gadea B, Shree T, Hunter K, Garfall A . IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 2010; 24(3):241-55. PMC: 2811826. DOI: 10.1101/gad.1874010. View